919 results on '"Eliakim R"'
Search Results
52. OC.02.4 EUROPEAN MULTICENTRE OBSERVATIONAL COHORT STUDY OF PANENTERIC CAPSULE ENDOSCOPY IN CROHN'S DISEASE: FEASIBILITY, SAFETY AND ROLE IN PATIENT MANAGEMENT
53. Letter: inflammatory bowel disease guidelines and conflicts of interest
54. Effects of Current Cigarette Smoking on Clinical Course of Crohn's Disease and Ulcerative Colitis
55. Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats
56. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines
57. The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD
58. CURRENT SMALL-BOWEL CAPSULE ENDOSCOPY PRACTICE: AN OFFICIAL ESGE SURVEY
59. A GUIDE FOR INTERPRETATION OF THE PERTINENCY OF SMALL BOWEL CAPSULE ENDOSCOPY FINDINGS: ANALYSIS OF 8064 ANSWERS OF INTERNATIONAL EXPERTS TO AN ILLUSTRATED SCRIPT QUESTIONNAIRE
60. ESGE GUIDELINES FOR SMALL-BOWEL CAPSULE ENDOSCOPY: FROM RECOMMENDATIONS TO PRACTICE
61. P643 Development of quantitative ultrasonographic activity score in ileal Crohn’s disease
62. P724 Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels
63. P160 A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease
64. P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the intervention
65. P012 α4β7 Receptor occupancy by vedolizumab at trough time-point occurs at the membranal level and is not associated with endoscopic healing in inflammatory bowel disease patients
66. Automated polyp detection system in colonoscopy using deep learning and image processing techniques
67. Hyperemesis gravidarum in the Clinical Setting
68. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis
69. Conventional dose of omeprazole alters gastric flora
70. Ketotifen and nitroxides decrease capsaicin-augmented ethanol-induced gastric damage in rats
71. Ketotifen ameliorates capsaicin-augmented acetic acid-induced colitis
72. Wireless capsule video endoscopy compared to barium follow-through and computerised tomography in patients with suspected Crohn’s disease—final report
73. Cytokines and platelet-activating factor in human inflamed colonic mucosa
74. A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule
75. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach
76. AUTOMATIC POLYP DETECTION IN COLONOSCOPY – GENERAL COMPARISON OF SYSTEM AND VIDEO ANALYSIS STATISTICS
77. CAPSULE RETENTION IN CROHN DISEASE: A META-ANALYSIS
78. P669 Transmural healing is associated with higher infliximab trough levels in Crohn’s disease
79. P285 Deep learning for automated detection of mucosal inflammation by capsule endoscopy in Crohn’s disease
80. P571 Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study
81. Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis
82. Abundance of surfactant-like particles reflects mucosal integrity in patients with peptic ulcer disease
83. A Possible Role for Rat Intestinal Surfactant-like Particles in Transepithelial Triacylglycerol Transport
84. Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study
85. Capsule endoscopy in young patients with iron deficiency anaemia and negative bidirectional gastrointestinal endoscopy
86. Vergleich der M2A Ösophaguskapsel (ECE) mit der konventionellen Endoskopie (EGD) in der Detektion von mukosalen Veränderungen der Speiseröhre bei Patienten mit GERD
87. Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor
88. P277 A new pan enteric capsule for suspected or established IBD: A feasibility study assessing the system functionality to visualise and assess the small and large bowels
89. P755 Safety, efficacy, and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-TNF
90. P486 Response to vedolizumab therapy in patients with inflammatory bowel disease: Impact of drug levels, anti-drug antibodies and α4β7 target occupancy
91. P239 The accuracy of intestinal ultrasound as compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileo-colonoscopy
92. P043 The effects of IBD biologic drugs on the propagation of lymphomatous transformation of EBV-infected peripheral blood mononuclear cells
93. P392 Comprehensive video capsule endoscopy-based monitoring predicts short and long-term risk of disease flares in small bowel Crohn’s disease: A prospective cohort study
94. P190 Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with Quiescent Small Bowel Crohn’s disease
95. Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy
96. Re‐phrasing the question: A simple tool for evaluation of adherence to therapy in patients with inflammatory bowel disease
97. Are we on our way to change our mode of thinking and treating inflammatory bowel disease patients?
98. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease
99. OR31: Short and Long Term Effect of Endoscopic Duodenal Sleeve for the Treatment of Diabetes and Obesity
100. N820 The value and perception of IBD patients on electronic news letter as a mode of patient-medical team communication
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.